6,986 research outputs found
The management of complicated colorectal cancer in older patients in a global perspective after {COVID-19}: the {CO-OLDER} {WSES} project
No full textBACKGROUND: Colorectal (CRC) cancer is becoming a disease of the
elderly. Ageing is the most significant risk factor for
presenting CRC. Early diagnosis of CRC and management is the
best way in achieving good outcomes and longer survival but
patients aged 75 years are usually not screened for CRC.
This group of patients is often required to be managed when they
are symptomatic in the emergency setting with high morbidity and
mortality rates. Our main aim is to provide clinical data about
the management of elderly patients presenting complicated
colorectal cancer who required emergency surgical management to
improve their care. METHODS: The management of complicated
COlorectal cancer in OLDER patients (CO-OLDER;
ClinicalTrials.gov ID: NCT05788224; evaluated by the local
ethical committee CPP EST III-France with the national number
2023-A01094-41) in the emergency setting project provides
carrying out an observational multicenter international cohort
study aimed to collect data about patients aged 75 years
to assess modifiable risk factors for negative outcomes and
mortality correlated to the emergency surgical management of
this group of patients at risk admitted with a complicated
(obstructed and perforated) CRC. The CO-OLDER protocol was
approved by Institutional Review Board and released. Each
CO-OLDER collaborator is asked to enroll 25 patients over
a study period from 1st January 2018 to 30th October 2023. Data
will be analyzed comparing two periods of study: before and
after the COVID-19 pandemic. A sample size of 240 prospectively
enrolled patients with obstructed colorectal cancer in a 5-month
period was calculated. The secured database for entering
anonymized data will be available for the period necessary to
achieve the highest possible participation. RESULTS: One hundred
eighty hospitals asked to be a CO-OLDER collaborator, with 36
potentially involved countries over the world. CONCLUSIONS: The
CO-OLDER project aims to improve the management of elderly
people presenting with a complicated colorectal cancer in the
emergency setting. Our observational global study can provide
valuable data on the effectiveness of different management
strategies in improving primary assessment, management and
outcomes for elderly patients with obstructed or perforated
colorectal cancer in the emergency setting, guiding clinical
decision-making. This information can help healthcare providers
make informed decisions about the best course of action for
these patients
The management of complicated colorectal cancer in older patients in a global perspective after COVID-19: the CO-OLDER WSES project
No full textBackground: Colorectal (CRC) cancer is becoming a disease of the elderly. Ageing is the most significant risk factor for presenting CRC. Early diagnosis of CRC and management is the best way in achieving good outcomes and longer survival but patients aged ≥75 years are usually not screened for CRC. This group of patients is often required to be managed when they are symptomatic in the emergency setting with high morbidity and mortality rates. Our main aim is to provide clinical data about the management of elderly patients presenting complicated colorectal cancer who required emergency surgical management to improve their care. Methods: The management of complicated COlorectal cancer in OLDER patients (CO-OLDER; ClinicalTrials.gov ID: NCT05788224; evaluated by the local ethical committee CPP EST III-France with the national number 2023-A01094-41) in the emergency setting project provides carrying out an observational multicenter international cohort study aimed to collect data about patients aged ≥75 years to assess modifiable risk factors for negative outcomes and mortality correlated to the emergency surgical management of this group of patients at risk admitted with a complicated (obstructed and perforated) CRC. The CO-OLDER protocol was approved by Institutional Review Board and released. Each CO-OLDER collaborator is asked to enroll ≥25 patients over a study period from 1st January 2018 to 30th October 2023. Data will be analyzed comparing two periods of study: before and after the COVID-19 pandemic. A sample size of 240 prospectively enrolled patients with obstructed colorectal cancer in a 5-month period was calculated. The secured database for entering anonymized data will be available for the period necessary to achieve the highest possible participation. Results: One hundred eighty hospitals asked to be a CO-OLDER collaborator, with 36 potentially involved countries over the world. Conclusions: The CO-OLDER project aims to improve the management of elderly people presenting with a complicated colorectal cancer in the emergency setting. Our observational global study can provide valuable data on the effectiveness of different management strategies in improving primary assessment, management and outcomes for elderly patients with obstructed or perforated colorectal cancer in the emergency setting, guiding clinical decision-making. This information can help healthcare providers make informed decisions about the best course of action for these patients
Coauthor prediction for junior researchers
No full textResearch collaboration can bring in different perspectives and generate more productive results. However, finding an appropriate collaborator can be difficult due to the lacking of sufficient information. Link prediction is a related technique for collaborator discovery; but its focus has been mostly on the core authors who have relatively more publications. We argue that junior researchers actually need more help in finding collaborators. Thus, in this paper, we focus on coauthor prediction for junior researchers. Most of the previous works on coauthor prediction considered global network feature and local network feature separately, or tried to combine local network feature and content feature. But we found a significant improvement by simply combing local network feature and global network feature. We further developed a regularization based approach to incorporate multiple features simultaneously. Experimental results demonstrated that this approach outperformed the simple linear combination of multiple features. We further showed that content features, which were proved to be useful in link prediction, can be easily integrated into our regularization approach. © 2013 Springer-Verlag
Our collaborators, Instructions for the author, Revue objectives, Life Proyect
No full textNuestros Colaboradores, Instrucciones para el Autor, Objetivos de la Revista y Proyecto de Vida de la Revista Páginas No.89Our collaborators, Instructions for the author, Revue objectives, Life Proyect of the Revue Páginas No.8
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.
No full textBackgroundGlobal evaluations of the progress towards the WHO End TB Strategy 2020 interim milestones on mortality (35% reduction) and incidence (20% reduction) have not been age specific. We aimed to assess global, regional, and national-level burdens of and trends in tuberculosis and its risk factors across five separate age groups, from 1990 to 2021, and to report on age-specific progress between 2015 and 2020.MethodsWe used the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 (GBD 2021) analytical framework to compute age-specific tuberculosis mortality and incidence estimates for 204 countries and territories (1990-2021 inclusive). We quantified tuberculosis mortality among individuals without HIV co-infection using 22 603 site-years of vital registration data, 1718 site-years of verbal autopsy data, 825 site-years of sample-based vital registration data, 680 site-years of mortality surveillance data, and 9 site-years of minimally invasive tissue sample (MITS) diagnoses data as inputs into the Cause of Death Ensemble modelling platform. Age-specific HIV and tuberculosis deaths were established with a population attributable fraction approach. We analysed all available population-based data sources, including prevalence surveys, annual case notifications, tuberculin surveys, and tuberculosis mortality, in DisMod-MR 2.1 to produce internally consistent age-specific estimates of tuberculosis incidence, prevalence, and mortality. We also estimated age-specific tuberculosis mortality without HIV co-infection that is attributable to the independent and combined effects of three risk factors (smoking, alcohol use, and diabetes). As a secondary analysis, we examined the potential impact of the COVID-19 pandemic on tuberculosis mortality without HIV co-infection by comparing expected tuberculosis deaths, modelled with trends in tuberculosis deaths from 2015 to 2019 in vital registration data, with observed tuberculosis deaths in 2020 and 2021 for countries with available cause-specific mortality data.FindingsWe estimated 9·40 million (95% uncertainty interval [UI] 8·36 to 10·5) tuberculosis incident cases and 1·35 million (1·23 to 1·52) deaths due to tuberculosis in 2021. At the global level, the all-age tuberculosis incidence rate declined by 6·26% (5·27 to 7·25) between 2015 and 2020 (the WHO End TB strategy evaluation period). 15 of 204 countries achieved a 20% decrease in all-age tuberculosis incidence between 2015 and 2020, eight of which were in western sub-Saharan Africa. When stratified by age, global tuberculosis incidence rates decreased by 16·5% (14·8 to 18·4) in children younger than 5 years, 16·2% (14·2 to 17·9) in those aged 5-14 years, 6·29% (5·05 to 7·70) in those aged 15-49 years, 5·72% (4·02 to 7·39) in those aged 50-69 years, and 8·48% (6·74 to 10·4) in those aged 70 years and older, from 2015 to 2020. Global tuberculosis deaths decreased by 11·9% (5·77 to 17·0) from 2015 to 2020. 17 countries attained a 35% reduction in deaths due to tuberculosis between 2015 and 2020, most of which were in eastern Europe (six countries) and central Europe (four countries). There was variable progress by age: a 35·3% (26·7 to 41·7) decrease in tuberculosis deaths in children younger than 5 years, a 29·5% (25·5 to 34·1) decrease in those aged 5-14 years, a 15·2% (10·0 to 20·2) decrease in those aged 15-49 years, a 7·97% (0·472 to 14·1) decrease in those aged 50-69 years, and a 3·29% (-5·56 to 9·07) decrease in those aged 70 years and older. Removing the combined effects of the three attributable risk factors would have reduced the number of all-age tuberculosis deaths from 1·39 million (1·28 to 1·54) to 1·00 million (0·703 to 1·23) in 2020, representing a 36·5% (21·5 to 54·8) reduction in tuberculosis deaths compared to those observed in 2015. 41 countries were included in our analysis of the impact of the COVID-19 pandemic on tuberculosis deaths without HIV co-infection in 2020, and 20 countries were included in the analysis for 2021. In 2020, 50 900 (95% CI 49 700 to 52 400) deaths were expected across all ages, compared to an observed 45 500 deaths, corresponding to 5340 (4070 to 6920) fewer deaths; in 2021, 39 600 (38 300 to 41 100) deaths were expected across all ages compared to an observed 39 000 deaths, corresponding to 657 (-713 to 2180) fewer deaths.InterpretationDespite accelerated progress in reducing the global burden of tuberculosis in the past decade, the world did not attain the first interim milestones of the WHO End TB Strategy in 2020. The pace of decline has been unequal with respect to age, with older adults (ie, those aged >50 years) having the slowest progress. As countries refine their national tuberculosis programmes and recalibrate for achieving the 2035 targets, they could consider learning from the strategies of countries that achieved the 2020 milestones, as well as consider targeted interventions to improve outcomes in older age groups.FundingBill & Melinda Gates Foundation
Types of Scientific Collaborators: A Perspective of Author Contribution Network
No full textThe purpose of this study is to investigate interaction between collaborators within individual studies by measuring how they made contributions to their studies. Author contribution network is constructed based on the author contribution statements of 140,000 full-text articles in PloS by viewing every collaborator as a node and a shared contribution as an edge. Three types of contributors are identified: general team-players, factotums, and mavericks. The preliminary result suggests that division of labor widely exists in scientific re-search and the latter two types of collaborators are common in small teams.Made available in DSpace on 2018-07-12T15:28:19Z (GMT). No. of bitstreams: 2
Lu-Chao_20180417_V01.pdf: 365239 bytes, checksum: 8e321b79b4d7f4e401a356426425f971 (MD5)
license.txt: 4802 bytes, checksum: 58353f9dd6876860dd5221f3d7872a95 (MD5)
Previous issue date: 201
An exploratory study of co-authorships among Iranian scientists in experimental sciences
No full textThis paper investigates the factors that made international co-authorship between scientists in Iran and elsewhere possible. A questionnaire was sent out to Iranian scientists in fields of physics, chemistry, and biology who had co-authored an internationally published journal article during 2003. The main foreign co-author in each of the articles was identified and questions regarding this co-author and the collaborative event were asked. The results show that not all co-authored articles were the results of collaborative projects. Also, the main collaborative motives behind the co-authorships were identified and described. Among these, we could mention sharing laboratory devices, accessing knowledge, and increase the efficiency of the study at hand. It is clear that emigrated Iranian scientists play an important role as collaborators and probably also as links to the international scientific community as a whole. Cultural factors mix with scientific and work related one
Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
No full textBackground: The health risks associated with moderate alcohol consumption continue to be debated. Small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year. Methods: For this analysis, we constructed burden-weighted dose-response relative risk curves across 22 health outcomes to estimate the theoretical minimum risk exposure level (TMREL) and non-drinker equivalence (NDE), the consumption level at which the health risk is equivalent to that of a non-drinker, using disease rates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020 for 21 regions, including 204 countries and territories, by 5-year age group, sex, and year for individuals aged 15-95 years and older from 1990 to 2020. Based on the NDE, we quantified the population consuming harmful amounts of alcohol. Findings: The burden-weighted relative risk curves for alcohol use varied by region and age. Among individuals aged 15-39 years in 2020, the TMREL varied between 0 (95% uncertainty interval 0-0) and 0·603 (0·400-1·00) standard drinks per day, and the NDE varied between 0·002 (0-0) and 1·75 (0·698-4·30) standard drinks per day. Among individuals aged 40 years and older, the burden-weighted relative risk curve was J-shaped for all regions, with a 2020 TMREL that ranged from 0·114 (0-0·403) to 1·87 (0·500-3·30) standard drinks per day and an NDE that ranged between 0·193 (0-0·900) and 6·94 (3·40-8·30) standard drinks per day. Among individuals consuming harmful amounts of alcohol in 2020, 59·1% (54·3-65·4) were aged 15-39 years and 76·9% (73·0-81·3) were male. Interpretation: There is strong evidence to support recommendations on alcohol consumption varying by age and location. Stronger interventions, particularly those tailored towards younger individuals, are needed to reduce the substantial global health loss attributable to alcohol. Funding: Bill & Melinda Gates Foundation
"Great Collaborators," Program, 2008
No full textProgram for the November 20, 2008 performance "Great Collaborators," co-directed by William Folger and Darrell Mullins
- …
